Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa

Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa


Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa

Acronym: HS2006
Other IDs: HS2006
NCT Number: NCT00795574
Sponsor Collaborators: Florida Academic Dermatology Centers
Funding: Other


HIDRADENITIS SUPPURATIVA CLINICAL TRIAL STATUS

Recruiting Status: Completed
Recruiting Genders: Both
Recruiting Age Groups: Child|Adult|Senior
Interventions: Drug: infliximab|Drug: Placebo Comparator
Phases: Phase 2


CLINICAL STUDY DETAILS & RESULTS

STUDY TYPES: Interventional
STUDY DESIGNS: Allocation: Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Crossover Assignment|Primary Purpose: Treatment|Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Results First Received: No Study Results Posted
Study Result (if available): No Results Available
Primary Completion Date: August 2008
Outcome Measures:


CLINICAL STUDIES DATES & MILESTONES

First Received: November 20, 2008
Start Date: June 2005
Completion Date: August 2008
Last Updated: November 21, 2008
last Verified: November 2008


Source: https://ClinicalTrials.gov/show/NCT00795574


Public Domain Source: ClinicalTrials.gov query for “Hidradenitis suppurativa” clinical studies (last updated January 2016).


Tags:
0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?